Impact of the Stool Color Scale on the Detection of Neonatal Cholestasis
Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06048211
Collaborator
(none)
100
1
4.7
21.4
Study Details
Study Description
Brief Summary
The stool color scale was set in 2018 in the health books of French children. The study aim is to see if the scale is usefull for healthcare professionals and if this scale has advanced the detection of neonatal cholestasis.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
The first part of the study consist in send a questionnaire to health professionnal to see their use of the stool color scale in the health book of newborn.
The second part of the study is to see the age of children with cholestasis at the date of the first consult with a specialist.
Study Design
Study Type:
Observational
Anticipated Enrollment
:
100 participants
Observational Model:
Other
Time Perspective:
Other
Official Title:
Impact of the Stool Color Scale in the French Health Book on the Detection of Neonatal Cholestasis
Anticipated Study Start Date
:
Sep 10, 2023
Anticipated Primary Completion Date
:
Dec 31, 2023
Anticipated Study Completion Date
:
Jan 30, 2024
Outcome Measures
Primary Outcome Measures
- use of stool color scale [4 month]
questionnaire
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
to 12 Months
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- cholestasis
Exclusion Criteria:
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | CHRU Nancy | Nancy | France |
Sponsors and Collaborators
- Central Hospital, Nancy, France
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT06048211
Other Study ID Numbers:
- 2022PI149
First Posted:
Sep 21, 2023
Last Update Posted:
Sep 21, 2023
Last Verified:
Sep 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: